Načítá se...
Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
OBJECTIVE: This surveillance study was conducted to verify the post-market safety and effectiveness of bevacizumab, which was approved in Japan in 2013 for the treatment of patients with newly diagnosed and or recurrent malignant glioma. METHODS: This was a prospective, observational, multicenter po...
Uloženo v:
| Vydáno v: | Jpn J Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923818/ https://ncbi.nlm.nih.gov/pubmed/31665343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyz125 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|